JP2022541634A - 疼痛に関連する睡眠障害を治療する方法 - Google Patents

疼痛に関連する睡眠障害を治療する方法 Download PDF

Info

Publication number
JP2022541634A
JP2022541634A JP2022504546A JP2022504546A JP2022541634A JP 2022541634 A JP2022541634 A JP 2022541634A JP 2022504546 A JP2022504546 A JP 2022504546A JP 2022504546 A JP2022504546 A JP 2022504546A JP 2022541634 A JP2022541634 A JP 2022541634A
Authority
JP
Japan
Prior art keywords
sleep
pain
fmsd
formula
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2022504546A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022541634A5 (https=
Inventor
ブラフンカ，ポール
マレック，ジェラード
トレイシー，キャセライン
ベス ブラウウェット，マリー
スミス，マイケル
ワルツア，マーク
イングリッシュ，マルシ
Original Assignee
アステラス ファーマ グローバル ディベロップメント，インコーポレーテッド．
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by アステラス ファーマ グローバル ディベロップメント，インコーポレーテッド． filed Critical アステラス ファーマ グローバル ディベロップメント，インコーポレーテッド．
Publication of JP2022541634A publication Critical patent/JP2022541634A/ja
Publication of JP2022541634A5 publication Critical patent/JP2022541634A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A61K31/5375—1,4-Oxazines, e.g. morpholine
    • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Anesthesiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2022504546A 2019-07-23 2020-07-22 疼痛に関連する睡眠障害を治療する方法 Pending JP2022541634A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962877573P 2019-07-23 2019-07-23
US62/877,573 2019-07-23
PCT/US2020/043047 WO2021016338A1 (en) 2019-07-23 2020-07-22 Methods of treating sleep disorders associated with pain

Publications (2)

Publication Number Publication Date
JP2022541634A true JP2022541634A (ja) 2022-09-26
JP2022541634A5 JP2022541634A5 (https=) 2023-07-28

Family

ID=72047043

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022504546A Pending JP2022541634A (ja) 2019-07-23 2020-07-22 疼痛に関連する睡眠障害を治療する方法

Country Status (10)

Country Link
US (1) US20220370468A1 (https=)
EP (1) EP4003357A1 (https=)
JP (1) JP2022541634A (https=)
KR (1) KR20220038344A (https=)
CN (1) CN114144183A (https=)
AU (1) AU2020318996A1 (https=)
BR (1) BR112022001056A2 (https=)
CA (1) CA3147752A1 (https=)
MX (1) MX2022000892A (https=)
WO (1) WO2021016338A1 (https=)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014196644A1 (ja) * 2013-06-06 2014-12-11 アステラス製薬株式会社 ベンゾチオフェン化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0320637D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
MX350745B (es) * 2009-11-06 2017-09-14 Sk Biopharmaceuticals Co Ltd * El uso de un compuesto de carbamoilo para el tratamiento del sindrome de fibromialgia.

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014196644A1 (ja) * 2013-06-06 2014-12-11 アステラス製薬株式会社 ベンゾチオフェン化合物

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
PAIN RESEARCH AND TREATMENT, vol. Vol. 2018, Article ID 7829427, JPN6025003652, 2018, pages 1 - 5, ISSN: 0005651141 *
ねむりと医療, vol. 3, no. 1, JPN6025003651, 2010, pages 28 - 33, ISSN: 0005651140 *

Also Published As

Publication number Publication date
KR20220038344A (ko) 2022-03-28
BR112022001056A2 (pt) 2022-05-24
MX2022000892A (es) 2022-03-11
AU2020318996A1 (en) 2022-02-03
CA3147752A1 (en) 2021-01-28
CN114144183A (zh) 2022-03-04
EP4003357A1 (en) 2022-06-01
WO2021016338A1 (en) 2021-01-28
US20220370468A1 (en) 2022-11-24

Similar Documents

Publication Publication Date Title
Backonja et al. Pharmacologic management part 1: better-studied neuropathic pain diseases
TWI663984B (zh) 神經疾病用藥臨床新應用
US20060122127A1 (en) Methods for reducing the side effects associated with mirtzapine treatment
US20250177378A1 (en) Treatment of depression
WO2013063263A1 (en) Pharmaceutical compositions for treating pain
Hauer et al. Pediatric pain and symptom management guidelines
CN119174751A (zh) 用于治疗焦虑相关病症的组合物和方法
JP4746714B2 (ja) 線維筋痛症治療用医薬組成物
Gleeson Symptom control in palliative care
JP2022541634A (ja) 疼痛に関連する睡眠障害を治療する方法
O’Neil Pain management
US20220401391A1 (en) Methods and compositions for treating pain
US20250367212A1 (en) Pharmacotherapy for obsessive-compulsive disorder targeting dopamine d1 signal in striatal striosomes
Kapoor et al. Challenges in the management of cancer pain in elderly population: A review
Hemraj et al. Persistent Pain in the Older Adult: Practical Considerations for
Kawahito et al. Successful treatment of mixed (mainly cancer) pain by tramadol preparations
Danami et al. Pain management and palliative care in the head and neck cancer setting
Ahn et al. Efficacy of Oxcarbazepine for Sleep-Related Leg Cramps: A Retrospective Study
ELsharkawy et al. Optimization of The Dose of Pregabalin as Pre-Anaesthetic Medication in Patients Undergoing Total Hip Arthroplasty Under Spinal Anaesthesia: Randomized Controlled Trial
JP2024537491A (ja) 大うつ病性障害の治療
Gowan et al. Disease state management: Pain management in older people-in aged care facilities and in the community
CN120051276A (zh) 减少对神经精神病学治疗的身体依赖性的方法
KATZ Pain in older people
Ford Management of chronic pain in community pharmacy
JPWO2009025091A1 (ja) 線維筋痛症治療用医薬組成物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20230720

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20230720

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20240612

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250204

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20250729